10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction

Bibliographic Details
Main Authors: F Muller, F Gsottberger, S Petkovic, A Mackensen, L Mellenthin, S Völkl, G Benintende, R Pelzl, K Wendland
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1827312603990327296
author F Muller
F Gsottberger
S Petkovic
A Mackensen
L Mellenthin
S Völkl
G Benintende
R Pelzl
K Wendland
author_facet F Muller
F Gsottberger
S Petkovic
A Mackensen
L Mellenthin
S Völkl
G Benintende
R Pelzl
K Wendland
author_sort F Muller
collection DOAJ
first_indexed 2024-04-24T21:46:05Z
format Article
id doaj.art-ad44be3caaee4d0c9e3a844faacfde46
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-04-24T21:46:05Z
publishDate 2024-03-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-ad44be3caaee4d0c9e3a844faacfde462024-03-20T22:15:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262024-03-0112Suppl 110.1136/jitc-2024-ITOC10.810.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunctionF Muller0F Gsottberger1S Petkovic2A Mackensen3L Mellenthin4S Völkl5G Benintende6R Pelzl7K Wendland8University Hospital of Erlangen, Erlangen, Germany1Universitätsklinikum Erlangen, Medizinische Klinik 5, Hämatologie und Onkologie, Erlangen, Germany1University Hospital of Erlangen, Erlangen, Germany1University Hospital of Erlangen, Erlangen, GermanyUniversity Hospital of Erlangen, Erlangen, Germany4Department of Internal Medicine 5 – Hematology/Oncology, University Hospital Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, GermanyUniversitätsklinukum Erlangen, Erlangen, Germany
spellingShingle F Muller
F Gsottberger
S Petkovic
A Mackensen
L Mellenthin
S Völkl
G Benintende
R Pelzl
K Wendland
10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
Journal for ImmunoTherapy of Cancer
title 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
title_full 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
title_fullStr 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
title_full_unstemmed 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
title_short 10.03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction
title_sort 10 03 long lasting alterations of the immunophenotype and cytokine signature of dlbcl survivors results in persisting immune dysfunction
work_keys_str_mv AT fmuller 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT fgsottberger 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT spetkovic 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT amackensen 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT lmellenthin 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT svolkl 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT gbenintende 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT rpelzl 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction
AT kwendland 1003longlastingalterationsoftheimmunophenotypeandcytokinesignatureofdlbclsurvivorsresultsinpersistingimmunedysfunction